TruBridge, Inc. (NASDAQ:TBRG) Major Shareholder Pinetree Capital Ltd. Purchases 6,795 Shares of Stock

TruBridge, Inc. (NASDAQ:TBRG) major shareholder Pinetree Capital Ltd. purchased 6,795 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were acquired at an average price of $28.16 per share, for a total transaction of $191,347.20. Following the acquisition, the insider now owns 729,176 shares of the company’s stock, valued at $20,533,596.16. This trade represents a 0.94 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Pinetree Capital Ltd. also recently made the following trade(s):

• On Thursday, February 13th, Pinetree Capital Ltd. purchased 74,981 shares of TruBridge stock. The shares were acquired at an average price of $27.61 per share, for a total transaction of $2,070,225.41.

TruBridge Trading Up 0.3 %

TBRG opened at $28.25 on Wednesday. TruBridge, Inc. has a 1-year low of $7.55 and a 1-year high of $28.70. The company has a current ratio of 1.80, a quick ratio of 1.78 and a debt-to-equity ratio of 1.00. The company has a market cap of $421.77 million, a P/E ratio of -6.91, a price-to-earnings-growth ratio of 4.90 and a beta of 0.69. The company has a fifty day moving average price of $22.24 and a two-hundred day moving average price of $16.56.

Institutional Investors Weigh In On TruBridge

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Covestor Ltd increased its stake in TruBridge by 20.5% in the fourth quarter. Covestor Ltd now owns 2,819 shares of the company’s stock valued at $56,000 after purchasing an additional 479 shares in the last quarter. Cubist Systematic Strategies LLC increased its stake in TruBridge by 2.0% in the fourth quarter. Cubist Systematic Strategies LLC now owns 26,202 shares of the company’s stock valued at $517,000 after purchasing an additional 514 shares in the last quarter. Tower Research Capital LLC TRC increased its stake in TruBridge by 47.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company’s stock valued at $43,000 after purchasing an additional 699 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in TruBridge by 1.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 73,879 shares of the company’s stock valued at $1,457,000 after purchasing an additional 716 shares in the last quarter. Finally, Trexquant Investment LP increased its stake in TruBridge by 14.4% in the fourth quarter. Trexquant Investment LP now owns 16,760 shares of the company’s stock valued at $331,000 after purchasing an additional 2,112 shares in the last quarter. 88.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. Stephens boosted their target price on shares of TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a report on Wednesday, November 20th. Barclays boosted their target price on shares of TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a report on Monday, November 11th.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.